Tumour cell kinetics as predictors of response in canine lymphoma treated with chemotherapy alone or combined with whole body hyperthermia

References

• ARMOUR, E. P., MCEACHERN, D., WANG, Z., CORRY, P. M., and MARTINEZ, A., 1993, Sensitivity of human cells to mild hyperthermia. Cancer Research, 53, 2740-2744. BEGG, A. C., 1989, Derivation of cell kinetic parameters from human tumours after labeling with bromodeoxyuridine or iododeoxyuridine. BIR Report, 19, 113–119.
   Google Scholar
• BEGG, A. C., HOFLAD, I., MOONEN, L., BARTELINK, H., SCHRAUB, S., BONTEMPS, P., LE FUR, R., VAN DEN BOGAERT, W., CASPERS, R., VAN GLABBEKE, M., and HORIOT, J. C., 1990, The predictive value of cell kinetic measurements in a European trial of acceler-ated fractionation in advanced head and neck tumors: an interim report. International Journal of Radiation Oncology, Biology, Physics, 19, 1449–1453.
   PubMed Web of Science ®Google Scholar
• BEGG, A. C., HOFLAD, I., VAN GLABEKKE, M., BARTELINK, H., and HORIOT, J. C., 1992, Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: results for the EORTC cooperative trial 22851. Seminars in Radiation Oncology, 2, 22–25.
   Google Scholar
• BEGG, A. C., MCNALLY, N. J., SHRIEVE, D. C., and KARCHER, H. A., 1985, A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry, 6, 620–626.
   PubMedGoogle Scholar
• BOTTI, G., CHIAPPETTA, G., D'Anno, G., DE ANGELIS, E., DE MATTEIS, A., MONTELLA, M., PICONE A., and CASCIONE, F., 1993, PCNA/cyclin and P-Glycoprotein as prognostic factors in locally advanced breast cancer. An immunohistochemical, retrospective study. Tumori, 79, 214–218.
   Google Scholar
• BRUCE, W. R., MEEKER, B. E., and VALERIOTE, F. A., 1966, Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-formulating cells to che-motherapeutic agents administered in vivo. Journal of the National Cancer Institute, 37, 233–245.
   PubMedGoogle Scholar
• CHoTr, A., AUGUSTIN, I., and WRBA, F., 1990, Peripheral T-cell lymphomas: A clinicopatho-logic study of 75 cases. Human Pathology, 21, 1117–1125.
   PubMedGoogle Scholar
• D'OLEIRE, F., SCHMITT, C. L., ROBINS, H. I., COHEN, D. J., and SPRIGGS, D., 1993, Cytokine induction in humans during 41.8 °C whole body hyperthermia. Journal of the National Cancer Institute, 85, 833–834.
   Google Scholar
• FIGGE, C., REIFENBERGER, G., VOGELEY, K. T, MESSING, M., ROOSEN, N., and WECHSLER, W., 1992, Immunohistochemical demonstration of proliferating cell nuclear antigen in glioblastomas: pronounced heterogeneity and lack of prognostic significance. Journal of Cancer Research Clinical Oncology, 118, 289–295.
   PubMed Web of Science ®Google Scholar
• FOX, M. H., and COULTER, J. R., 1980, Enhanced light collection in a flow cytometer. Cytometry, 1, 21–25.
   PubMedGoogle Scholar
• FOX, M. H., ARMSTRONG, L W., WITHROW, S. J., POWERS, B. E., LARuE, S. M., STRAW, R. C., and GILLETTE, E. L, 1990, Comparison of DNA aneuploidy of primary and metastatic spontaneous canine osteosarcomas. Cancer Research, 50, 6176–6178.
   PubMedGoogle Scholar
• GIORDANO, M., DANOVA, M., MAZZINI, G., GOBBI, P., and RICCARDI, A., 1993, Cell kinetics with in vivo bromodeoxyuridine assay, proliferating cell nuclear antigen expression and flow cytometric analysis. Cancer, 71, 2739–2745.
   PubMed Web of Science ®Google Scholar
• GROGAN, T M., and MILLER, T. P., 1993, Immunobiologic correlates of prognosis in lym-phoma. Seminars in Oncology, 20, 58–74.
   PubMedGoogle Scholar
• GROGAN, T. M., LIPPMAN, S. M., and SPIER, C. M., 1988, Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki67. Blood, 71, 1157–1160.
   PubMed Web of Science ®Google Scholar
• HALL, P. A., RICHARDS, M. A., and GREGORY, W. M., 1988, The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. Journal of Pathology, 154, 223–235.
   PubMed Web of Science ®Google Scholar
• HARTMANN, L. C., SEBO, T. J., KAMEL, N. A., PODRATZ, K. C., CHA, S. S., WIFAND, H. S., KEENEY, G. L., and ROCHE, P. C., 1992, Proliferating cell nuclear antigen in epithelial ovarian cancer: relation to results at second-look laparotomy and survival. Gynecology—Oncology, 47, 191–195.
   PubMedGoogle Scholar
• HICKEY, K., GREHAN, D., REID, I. M., O'BRIAN, S., WALSH, T. N., and HENNESSY, T. P., 1994, Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiother-apy. Cancer, 74, 1693–1698.
   Google Scholar
• JAKIC-RUZUMOVIC, J., TENTOR, D., PETROVECKI, M., and RADMAN, I., 1993, Nucleolar organizer regions and survival in patients with non-Hodgkin's lymphomas classified by the working formulation. Journal of Clinical Pathology, 46, 943–950.
   PubMedGoogle Scholar
• KApp, D. S., 1996, Thermal dose response, systemic hyperthermia and metastases: old friends revisited. International Journal of Radiation Oncology, Biology, Physics, 35, 189–194. LARuE, S. M., 1992, Analysis of tumor cell kinetics and its application in canine osteosar- coma. Ph.D. Dissertation, Colorado State University.
   Google Scholar
• LIMP, P. F., KApp, D. S., and MORROW, D. L., 1981, Increased skeletal metastases of spon-taneous canine osteosarcoma after fractionated systemic hyperthermia and local X—irradiation. Cancer Research, 41, 4332–4334.
   Google Scholar
• MAYER, A., TAKIMOTO, M., FRITZ, E., SCHELLANDER, G., KOELER, K., and LUDWIG, H., 1993, The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr. gene expression in colorectal cancer. Cancer, 71, 2454–2460.
   PubMed Web of Science ®Google Scholar
• NANJYO, T., WATANABE, Y., and IKEDA, M., 1994, The correlation between the therapeutic effects and the tumor growth fraction in cervical cancer and ovarian cancer. Nippon-Sanka-Fujinka-Gakkai-Zasshi, 46, 27–34.
   PubMedGoogle Scholar
• NOVOTNEY, C. A., PAGE R. L., MACY, D. W., DEWHIRST, M. W., OGILVIE, G. K., WITHROW, S. J., MCENTEE, M. C., HEIDNER, G. L, ALLEN, S. A., THRALL, D. E., and GILLETTE, E. L., 1992, Phase I evaluation of doxorubicin and whole-body hyper-thermia in dogs with lymphoma. Journal of Veterinary Internal Medicine, 16, 4, 245–249.
   Google Scholar
• ORMEROD, M. G., ImmE, P. R., LOVEROCK, P., and TER-HARR, G., 1992, A flow cytometric study of the effect of heat on the kinetics of cell proliferation of Chinese hamster V-79 cells. Cell Proliferation, 25, 41–45.
   Google Scholar
• PEAK, J. G., BLAZEK, E. R., and PEAK, M. J., On the measurement of DNA double-strand breaks by neutral elution (letter; comment). Radiation Research, 122, 104–105.
   Google Scholar
• ROBINS, H. I., KUTZ, M., WIEDEMANN, G. J., KATSCHINSKE, D. M., PAUL, D., CROSEN, E., TIGGELAAR, C. L, SPRIGGS, D., GILLIS, W., and D'OLEIRE, F., 1995, Cytokine induc-tion by 41.8°C whole body hyperthermia. Cancer Letters, 97, 195–201.
   Google Scholar
• SI, R. N., HORNBACK, N. B., SHIDNIA, H., Wu, B., Lu, L., and BROXMEYER, H. E., 1991, Whole body hyperthermia: a potent radioprotector in vivo. International Journal of Radiation Oncology, Biology, Physics, 20, 525–530.
   PubMedGoogle Scholar
• TANAKA, Y., UEMATSU, Y., ITAKURA, T, and KOMAI, N., 1994, Clinicopathological study of lymphomas in the central nervous system—with the reference to the recurrence and proliferation activity. Noshuyo-Byori, 11, 181–186.
   PubMedGoogle Scholar
• TANNOCK, I. F., 1987, Biological properties of anticancer drugs. In The Basic Science of Oncology, edited by I. F. Tannock and R. P. Hill (New York: Pergamon Press), pp. 278–291.
   Google Scholar
• THE NON-HODGKIN&S LYMPHOMAPATHOLOGIC CLASSIFICATION PROJECT (1982) National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a Working Formulation for Clinical Usage. Cancer, 49, 2112.
   Google Scholar
• THRALL, D. E., PAGER. L., DEWHIRST, M. W., MACY, D. W., McLEop, D. A., SCOTT, R. J., ALLEN, S., and GILLETTE, E. L., 1989, Whole body hyperthermia in dogs using a radiant heating device: effect of surface cooling on temperature uniformity. International Journal of Hyperthermia, 5, 137–143.
   Google Scholar
• THRALL, D. E., PAGE, R. L, DEWHIRST, M. W., MEYER, R. E., HOOPES, J. P., and KORNEGAY, J. N., 1986, Temperature measurements in normal and tumor tissue of dogs undergoing whole body hyperthermia. Cancer Research, 46, 6229–6235.
   PubMed Web of Science ®Google Scholar
• THRALL, D. E., PRESCOTT, D. M., SAMULSKI, T. V., ROSNER, G. L., DENMAN, D. L., LEGORETTA, R. L., DODGE, R. K., PAGE, R. L, CLINE, J. M., I FE, J., CASE, B. C., EVANS, S. M., OLESON, J. R., and DEWHIRST, M. W., 1996, Radiation plus local hyper-thermia versus radiation plus the combination of local and whole body hyperthermia in canine sarcomas. International Journal of Radiation Oncology, Biology, Physics, 34, 1087–1096.
   PubMed Web of Science ®Google Scholar
• TWENTYMAN, P. R., and BLEEBEN, N. M., 1975, Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line. British Journal of Cancer, 31, 412–423.
   Google Scholar
• VAIL, D. M., KISSEBERTH, W. C., OBRADOVICH, J. E., MOORE, F. M., LONDON, C. A., MACEWEN, E. G., and RITTER, M. A., 1996, Assessment of potential doubling time (T0), argyrophilic nucleolar organizer regions (AgNOR) and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Experimental Hematology, 24, 807–815.
   PubMed Web of Science ®Google Scholar
• VAN PUTTEN, L. M., LELlEVELD, P., and KRAM-IDSENGA, L. K. J., Cell cycle specificity and therapeutic effectiveness of cytostatic agents. Cancer Chemotherapy Reports, 56, 691–700.
   Google Scholar
• WILSON, G. D., MCNALLY, N. J., DUNPHY, E., KARCHER, H., and PFAGNER, R., 1985, The labeling index of human and mouse tumors assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry, 6, 641–647.
   PubMedGoogle Scholar
• ZOLZER, F., DEVI, P. U., and STREFFLER, C., 1994, Determination of potential doubling times in human melanoma cell cultures subjected to irradiation and/or hyperthermia by flow cytometry. Radiation Research, 138, 451–459.
   PubMedGoogle Scholar